FDA to Expand Unannounced Inspections at Foreign Manufacturing Facilities

The expansion builds upon the agency’s Office of Inspection and Investigations Foreign Unannounced Inspection Pilot program in India and China and aims to ensure that foreign companies receive the same level of regulatory oversight as domestic companies.